Sign inGet started

Deep Track Biotechnology Master Fund, Ltd.

Insider CIK 2015536 · DVAX 10% owner · LBRX 10% owner · ATTO 10% owner · NKTR 10% owner

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
ATTO Attovia Therapeutics, Inc. C Conversion deriv2026-08-062026-08-1018,181,818— $00SEC↗
ATTO Attovia Therapeutics, Inc. C Conversion2026-08-062026-08-101,957,138— $01,957,138SEC↗
ATTO Attovia Therapeutics, Inc. C Conversion deriv2026-08-062026-08-1018,181,818— $0—SEC↗
ATTO Attovia Therapeutics, Inc. C Conversion2026-08-062026-08-101,957,138— —1,957,138SEC↗
LBRX LB PHARMACEUTICALS INC P Buy deriv2026-07-302026-08-03286,205$34.94 $10.00M664,649SEC↗
LBRX LB PHARMACEUTICALS INC P Buy deriv2026-07-302026-08-03286,205$34.94 $10.00M664,649SEC↗
DVAX DYNAVAX TECHNOLOGIES CORP U Tender2026-02-102026-02-1115,726,349— $00SEC↗
LBRX LB PHARMACEUTICALS INC P Buy deriv2026-02-062026-02-10378,444$21.17 $8.01M378,444SEC↗
LBRX LB PHARMACEUTICALS INC P Buy deriv2026-02-062026-02-1093,925$21.17 $1.99M93,925SEC↗
LBRX LB PHARMACEUTICALS INC C Conversion deriv2025-09-122025-09-1616,666,667— $00SEC↗
LBRX LB PHARMACEUTICALS INC P Buy2025-09-122025-09-16666,666$15.00 $10.00M666,666SEC↗
LBRX LB PHARMACEUTICALS INC P Buy2025-09-122025-09-162,000,000$15.00 $30.00M2,686,138SEC↗
LBRX LB PHARMACEUTICALS INC C Conversion2025-09-122025-09-16686,138— $0686,138SEC↗
DVAX DYNAVAX TECHNOLOGIES CORP S Sale2025-08-222025-08-22970,143$10.59 $10.27M15,726,349SEC↗
DVAX DYNAVAX TECHNOLOGIES CORP S Sale2025-08-212025-08-221,094,994$11.03 $12.08M16,696,492SEC↗
NKTR NEKTAR THERAPEUTICS S Sale2024-05-102024-05-1356,000$1.78 $99.7K18,344,000SEC↗